Active substances
Dextromethorphan + Guaifenesin
- SFDA 6
- US FDA 7
- Health Canada 11
- US price lines 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CONTRA 15/200 mg softgel capsule | 15,200 mg,mg | Capsule, soft · Oral use | 30 Blister | SAR 29.75 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| GUAPHAN DM | 100,10 mg,mg | Syrup · Oral use | 1 Bottle | SAR 12.20 | Generic · Prescription | RIYADH PHARMA | Valid |
| CHERACHOL-D SYRUP | 2, 20 mg/ml | Oral solution · Oral use | 1 Bottle | SAR 9.30 | NCE · OTC | PHARMACIA UPJOHN | Withdrawn by MAH · Not Marketed |
| KAFOSED G SYRUP | Syrup · Oral use | 1 Bottle | SAR 5.15 | Generic · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed | |
| ROBITUSSIN-DM SYRUP | 3, 20 mg | Syrup · Oral use | 1 Bottle | SAR 7.40 | Generic · Prescription | FEREVA RICHMOND | Withdrawn by MAH · Not Marketed |
| VICKS 44 E PEDIATRIC ALCOHOL FREE SYRUP | 100,10 mg,mg | Syrup · Oral use | 1 Bottle | SAR 5.10 | Generic · Prescription | PROCTER & GAMBLE | Withdrawn by regulatory authority · Not Marketed |
Indications — CHI Daman Drug Formulary
BACTERIAL TONSILLOPHARYNGITIS TREATMENT AND PREVENTION
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MUCINEX DM | 60MG;1.2GM; 30MG;600MG | tablet, extended release · oral | RECKITT BENCKISER | Over-the-counter | 29 Apr 2004 |
| GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG; 60MG;1.2GM | tablet, extended release · oral | ACTAVIS LABS FL | Over-the-counter | 31 Aug 2015 |
| GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG; 60MG;1.2GM | tablet, extended release · oral | AUROBINDO PHARMA | Over-the-counter | 17 Mar 2017 |
| GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 60MG;1.2GM; 30MG;600MG | tablet, extended release · oral | PERRIGO R AND D | Over-the-counter | 5 Mar 2018 |
| GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG; 60MG;1.2GM | tablet, extended release · oral | AMNEAL PHARMS | Over-the-counter | 1 Nov 2018 |
| GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG; 60MG;1.2GM | tablet, extended release · oral | SUN PHARM | Over-the-counter | 1 Jul 2021 |
| GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 30MG;600MG; 60MG;1.2GM | tablet, extended release · oral | DR REDDYS | Over-the-counter | 1 Aug 2023 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| BENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEF | 01944762 | 15 MG / 5 ML; 100 MG / 5 ML | SYRUP · ORAL | KENVUE CANADA INC. |
| COUGH & CHEST CONGESTION | 02539195 | 20 MG / 20 ML; 400 MG / 20 ML | SYRUP · ORAL | LSL MEDPLUS INC |
| COUGH & CHEST CONGESTION EXTRA STRENGTH | 02541890 | 15 MG / 5 ML; 200 MG / 5 ML | SYRUP · ORAL | CRLS |
| COUGH & CHEST CONGESTION REGULAR STRENGTH | 02541882 | 100 MG / 5 ML; 15 MG / 5 ML | SYRUP · ORAL | CRLS |
| JACK & JILL HONEY COUGH & COLD | 02522950 | 50 MG / 5 ML; 5 MG / 5 ML | SYRUP · ORAL | HALEON CANADA ULC |
| MUCINEX CONGESTION & COUGH | 02433257 | 20 MG / 20 ML; 400 MG / 20 ML | SOLUTION · ORAL | RECKITT BENCKISER (CANADA) INC |
| MUCUS & PHLEGM RELIEF WITH COUGH CONTROL EXTRA STRENGTH | 02540908 | 200 MG / 5 ML; 15 MG / 5 ML | SYRUP · ORAL | CRLS |
| ROBITUSSIN COUGH CONTROL | 01931024 | 100 MG / 5 ML; 15 MG / 5 ML | SYRUP · ORAL | HALEON CANADA ULC |
| ROBITUSSIN EXTRA STRENGTH COUGH CONTROL | 02142775 | 15 MG / 5 ML; 200 MG / 5 ML | SYRUP · ORAL | HALEON CANADA ULC |
| ROBITUSSIN EXTRA STRENGTH HONEY COUGH & CONGESTION | 02485524 | 400 MG / 20 ML; 20 MG / 20 ML | SYRUP · ORAL | HALEON CANADA ULC |
| ROBITUSSIN SUGAR FREE COUGH CONTROL | 02248568 | 10 MG / 5 ML; 100 MG / 5 ML | SYRUP · ORAL | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | GUAIFENESIN-DM 100-10 MG/5 ML | $0.02395 | per ML | 23 Sep 2026 |
| US NADAC | GUAIFENESIN-DM ER 1,200-60 MG | $0.54461 | per EA | 7 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.